Objectives

After participating in this educational activity, attendees should be able to:

1| Review key updates to MS McDonald Criteria and their impact on diagnosis.
2| Discuss current treatment approaches for Multiple Sclerosis.
3| Highlight emerging therapies for progressive Multiple Sclerosis.

Presenter(s): 
Dr. Sarah Conway 
Associate Neurologist, Division of Neuroimmunology, Department of Neurology
Mass General Brigham 
Instructor of Neurology
Harvard Medical School

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Sarah E. Conway, MDSpeaker/AuthorNeurology Live-Advisory BoardNo
Session date: 
01/07/2026 - 9:00am to 10:00am EST
Location: 
ZOOM
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.